4.9
51 Ratings with 31 written Reviews
Summary
%uF0A7 Weight Gain in Advanced Non-Small Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy Is Associated With Superior Survival. Gielda, Mehta, Khan, Marsh, Zusag, Warren, Fidler, Abrams, Bonomi, Liptay, and Faber. International Journal of Radiation Oncology Biology Physics. Vol 81. No 4. Pp. 985-991, 2011.
%uF0A7 Mehta, Halpern, et al. Basal and Squamous Cell Skin Cancers. Head and Neck Cancer, A Multidisciplinary Approach, Lippincott Williams & Wilkins, 3rd Edition, 2008, pp 544-560.
%uF0A7 Function and Organ Preservation in Adult Cancers of the Head and Neck. Expert Review of Anticancer Therapy. Mar 2007, 7(3); pages 361-371. Mehta PS and Harrison LB.
%uF0A7 A Dosimetric Comparison of three-dimensional conformal, intensity-modulated radiation therapy, and MammoSite partial-breast irradiation. Brachytherapy, Vol. 5, Issue 3, Jul-Sep 2006, pages 183-188. Khan AJ, Kirk MC, Mehta PS, Seif NS, Griem KL, Bernard DA, Chu JC, Dickler A.
%uF0A7 Split …course radiotherapy with concurrent, cytotoxic chemotherapy for stage III non-small cell lung cancer: decreased acute and late toxicity without compromised efficacy. Mehta PS, Khan AJ, Zusag TW, Bonomi PD, Faber LP, Villaflor V, Abrams RA. Oral Presentation RSNA 2005.
%uF0A7 Is aggressive local-regional management warranted with oligometastatic non-small cell lung? Khan AJ, Mehta PS, Zusag TW, Bonomi PD , Faber LP, Abrams RA.
%uF0A7 Initial Clinical Results with the Mammosite Breast Brachytherapy Applicator in Women with Early-Stage Breast Cancer. Choo JJ, Mehta PS, Nguyen CN, Hasabou N, Schochet E, Gittleman MA, Henson R, Snider HC, Dowlatshahi K. Abstract ASTRO 2005.
%uF0A7 A dosimetric analysis comparing an electron tumor bed boost with a tumor bed boost utilizing the Mammosite breast brachytherapy applicator. Kirk M, Dickler AD, Mehta PS, Khan AJ, Chu J, Griem KL, Nguyen C. Abstract ASTRO 2005.
%uF0A7 A dosimetric comparison of 3D conformal, IMRT, and Mammosite partial breast radiation. Dickler A, Kirk M, Khan AJ, Mehta PS, Chu J, Griem KL, and Nguyen C. Abstract ASTRO 2005.
%uF0A7 Clonogenic survival does not uniformly increase with split time between halves of 2-Gy fractions: implications for IMRT. Blazek ER, Khan AJ, Mehta PS, Foutch JL, Kirk MC, Chu J, Abrams RA. Poster Radiation Research Society 2005.
%uF0A7 Is Nodal Irradiation Necessary in Breast Cancer Patients with Positive Sentinel Node Biopsy Without Axillary Dissection? IJROBP, Vol. 54, Issue 2, Supplement 1, 1 October 2002, pages 232-233. Sarvi M, Mehta P, Vallow L, Dowlat K, Griem KL.
Read More Read less %uF0A7 Mehta, Halpern, et al. Basal and Squamous Cell Skin Cancers. Head and Neck Cancer, A Multidisciplinary Approach, Lippincott Williams & Wilkins, 3rd Edition, 2008, pp 544-560.
%uF0A7 Function and Organ Preservation in Adult Cancers of the Head and Neck. Expert Review of Anticancer Therapy. Mar 2007, 7(3); pages 361-371. Mehta PS and Harrison LB.
%uF0A7 A Dosimetric Comparison of three-dimensional conformal, intensity-modulated radiation therapy, and MammoSite partial-breast irradiation. Brachytherapy, Vol. 5, Issue 3, Jul-Sep 2006, pages 183-188. Khan AJ, Kirk MC, Mehta PS, Seif NS, Griem KL, Bernard DA, Chu JC, Dickler A.
%uF0A7 Split …course radiotherapy with concurrent, cytotoxic chemotherapy for stage III non-small cell lung cancer: decreased acute and late toxicity without compromised efficacy. Mehta PS, Khan AJ, Zusag TW, Bonomi PD, Faber LP, Villaflor V, Abrams RA. Oral Presentation RSNA 2005.
%uF0A7 Is aggressive local-regional management warranted with oligometastatic non-small cell lung? Khan AJ, Mehta PS, Zusag TW, Bonomi PD , Faber LP, Abrams RA.
%uF0A7 Initial Clinical Results with the Mammosite Breast Brachytherapy Applicator in Women with Early-Stage Breast Cancer. Choo JJ, Mehta PS, Nguyen CN, Hasabou N, Schochet E, Gittleman MA, Henson R, Snider HC, Dowlatshahi K. Abstract ASTRO 2005.
%uF0A7 A dosimetric analysis comparing an electron tumor bed boost with a tumor bed boost utilizing the Mammosite breast brachytherapy applicator. Kirk M, Dickler AD, Mehta PS, Khan AJ, Chu J, Griem KL, Nguyen C. Abstract ASTRO 2005.
%uF0A7 A dosimetric comparison of 3D conformal, IMRT, and Mammosite partial breast radiation. Dickler A, Kirk M, Khan AJ, Mehta PS, Chu J, Griem KL, and Nguyen C. Abstract ASTRO 2005.
%uF0A7 Clonogenic survival does not uniformly increase with split time between halves of 2-Gy fractions: implications for IMRT. Blazek ER, Khan AJ, Mehta PS, Foutch JL, Kirk MC, Chu J, Abrams RA. Poster Radiation Research Society 2005.
%uF0A7 Is Nodal Irradiation Necessary in Breast Cancer Patients with Positive Sentinel Node Biopsy Without Axillary Dissection? IJROBP, Vol. 54, Issue 2, Supplement 1, 1 October 2002, pages 232-233. Sarvi M, Mehta P, Vallow L, Dowlat K, Griem KL.
Quick Facts
- 25 years of experience
- 48 insurance plans accepted
- speaks Polish, Spanish
- University Of Illinois At Chicago College Of Medicine
- 31 written reviews
- 1 specialty
- 5 areas of expertise
- 1 board certification
- 1 hospital affiliation
- 2 office locations
- Male
Office Locations
Dr. Parthiv Suresh Mehta has 2 locationsRadiation Oncologist Glenview Cancer Treatment Center
2600 Patriot Blvd Ste JGlenview, IL 60026Mon7:00 am - 4:00 pm
Tue7:00 am - 4:00 pm
Wed7:00 am - 4:00 pm
Thu7:00 am - 4:00 pm
Fri7:00 am - 4:00 pm
SatClosed
SunClosed
Compare with Similar Doctors
 |  |  |  |
| Dr. Parthiv Suresh Mehta, MD | Dr. Abhishek A Solanki, MD | Dr. Tamer M Refaat, PhD, MD | Dr. William Small, MD |
| Radiation Oncology | Radiation Oncology | Radiation Oncology | Radiation Oncology |
| Accepts New Patients | Accepts New Patients | Accepts New Patients | |
| 25 Years of Experience | 36 Years of Experience | ||
| No Virtual Visit Option | No Virtual Visit Option | No Virtual Visit Option | No Virtual Visit Option |
| Speaks Polish, Spanish | Speaks Spanish, English | Speaks English, Spanish | |
| Glenview , IL | Maywood , IL | Maywood , IL | Maywood , IL |
| Med School: University Of Illinois At Chicago College Of Medicine | Med School: Northwestern University Feinberg School Of Medicine | ||
Current Profile | View Profile | View Profile | View Profile |
Insurance Plans Accepted by Dr. Parthiv Suresh Mehta
Medical Specialties
Dr. Parthiv Suresh Mehta has the following specialty
Specialty Expertise
Dr. Parthiv Suresh Mehta has the following 5 areas of expertise
Certifications, License, & Education
25 Years Experience
MEDICAL LICENSE
Medical Doctor, Illinois, 2026, Active
EDUCATION & TRAINING
Medical School
University Of Illinois At Chicago College Of MedicineGraduated in 2001
Similar doctors
Frequently Asked Questions
- Where is Dr. Parthiv Mehta's office located?
- Dr. Parthiv Mehta's office is located at 2600 Patriot Blvd Ste J, Glenview, IL, 60026.
- Is Dr. Parthiv Mehta accepting new patients?
- Dr. Parthiv Mehta has not indicated that they accept new patients. Contact their office through their Vitals profile to check for availability.
- Does Dr. Parthiv Mehta accept my insurance?
- You can see the insurance plans that Dr. Parthiv Mehta accepts on their Vitals profile.
- Does Dr. Parthiv Mehta accept virtual/telehealth appointments?
- Dr. Parthiv Mehta has not indicated that they accept virtual/teleheatlh appointments. Contact their office through their Vitals profile to check for availability.
- Which hospitals is Dr. Parthiv Mehta affiliated with?
- Dr. Parthiv Mehta is affiliated with Rush Copley Medical Center.
Ensuring Data Transparency and Trust: A Guide to Vitals Doctor Listings and Reviews
Our provider data is gathered directly from physicians and publicly available databases. Providers who verify their profiles gain the ability to update information, offering additional details about their specialties,education, treated conditions, performed procedures, and accepted insurances.
Reviews on Vitals are submitted by users only. Recognizing the valuable insights these reviews offer into a doctor's reputation, we maintain internal policies and protocols to ensure the quality and accuracy of all reviews. Importantly, providers cannot delete or alter reviews independently. Reviews can only be deleted or changed following an internal assessment by our customer service team.
Your feedback is highly valued and we encourage you to contact our support team should you encounter any issues.
